Loading organizations...
§ Venture Capital · Busan, Pusan-jikhalsi, South Korea
Maple Investment Partners operates as a Busan-based venture capital firm providing private equity investments to small and medium-sized businesses. The firm strategically invests across diverse sectors, including agribusiness, biotechnology, technology, healthcare, and leisure. Their investment approach is customer-centric, delivering capital and strategic guidance to accelerate portfolio company growth.
Established in 2008, Maple Investment Partners was founded on the insight that dedicated support for emerging venture companies and SMEs drives significant economic expansion. Its inception demonstrated a commitment to fostering shared success by partnering with innovative South Korean enterprises, empowering them with crucial resources.
The firm serves high-potential venture companies and SMEs seeking strategic capital and collaborative expansion. Maple Investment Partners focuses on active partnership to ensure sustainable scaling and market integration for its portfolio. Its vision is to collaboratively build growth and contribute to the successful evolution of dynamic businesses within key industries.
Maple Investment Partners has 2 tracked investments across 2 companies. The latest tracked deal is $41.8M Series B in Illimis Therapeutics in July 2025.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jul 14, 2025 | Illimis Therapeutics | $41.8M Series B | Yohan KIM | AJU IB Investment, A Ventures, Company K Partners, Daily Partners, GS Ventures, Hana Ventures, IMM Investment, Industrial Bank OF Korea, Korea Development Bank, LB Investment, Quad Investment Management, Schmidt, Shinhan Venture Investment, S&S Investment, TS Investment, Jiwoong Chun |
| Mar 13, 2024 | Algocare | $11.0M Series A | Starset Investment | Company K Partners, JB Investment, L&S Venture Capital, Murex Partners, Small And Medium Business Bank |